Dayton Misfeldt - Net Worth and Insider Trading
Dayton Misfeldt Net Worth
The estimated net worth of Dayton Misfeldt is at least $37 dollars as of 2024-11-28. Dayton Misfeldt is the Director of Sunesis Pharmaceuticals Inc and owns about 7 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $37. Details can be seen in Dayton Misfeldt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dayton Misfeldt has not made any transactions after 2017-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dayton Misfeldt
Dayton Misfeldt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dayton Misfeldt owns 3 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , Interleukin Genetics Inc (ILIU) , and Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Dayton Misfeldt’s form 4 insider trades.
Insider Ownership Summary of Dayton Misfeldt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNSS | Sunesis Pharmaceuticals Inc | 2020-06-30 | director & See Remarks |
| ILIU | Interleukin Genetics Inc | 2013-05-17 | director |
| VIRX | Viracta Therapeutics Inc | 2019-06-28 | director & Interim CEO |
Dayton Misfeldt Latest Holdings Summary
Dayton Misfeldt currently owns a total of 1 stock. Dayton Misfeldt owns 7 shares of Sunesis Pharmaceuticals Inc (SNSS) as of October 27, 2017, with a value of $37.
Latest Holdings of Dayton Misfeldt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNSS | Sunesis Pharmaceuticals Inc | 2017-10-27 | 7 | 5.32 | 37 |
Holding Weightings of Dayton Misfeldt
Dayton Misfeldt Form 4 Trading Tracker
According to the SEC Form 4 filings, Dayton Misfeldt has made a total of 0 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 11,429 shares on October 27, 2017, which cost Dayton Misfeldt around $800,000.
Insider Trading History of Dayton Misfeldt
- 1
Dayton Misfeldt Trading Performance
GuruFocus tracks the stock performance after each of Dayton Misfeldt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dayton Misfeldt is 42.22%. GuruFocus also compares Dayton Misfeldt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dayton Misfeldt within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dayton Misfeldt's insider trading performs compared to the benchmark.
Performance of Dayton Misfeldt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.88 | | | | | |
| Relative Return to S&P 500(%) | 24.25 | | | | | |
Dayton Misfeldt Ownership Network
Dayton Misfeldt Owned Company Details
What does Sunesis Pharmaceuticals Inc do?
Who are the key executives at Sunesis Pharmaceuticals Inc?
Dayton Misfeldt is the director & See Remarks of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include VP & Finance Tina Gullotta , See Remarks Judith A. Fox , and See Remarks William P. Quinn .
Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sunesis Pharmaceuticals Inc Insider Transactions
Dayton Misfeldt Mailing Address
Above is the net worth, insider trading, and ownership report for Dayton Misfeldt. You might contact Dayton Misfeldt via mailing address: C/o Bay City Capital Llc, 750 Battery Street, Suite 400, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
